Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tri-Luma Cream and IPL for Melasma
NCT00669071Phase 4Terminated
- Sponsor
- Galderma
- Start
- Jan 2008
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tretinoin in melasma, sponsored by Galderma. Started Jan 2008; status: terminated.
02
Drugs
tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on NCT00669071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00669071.